Premium Company Profile: Invitrogen Corporation

Invitrogen is a developer, manufacturer and marketer of diagnostic and research products, and services that support academic and government research institutions, and pharmaceutical and biotech companies. The company operates through two business segments, namely, BioDiscovery and Cell Culture Systems (formerly known as BioProduction).

Report Highlights
Invtirogen's product offerings target life science researchers and commercial producers of biopharmaceutical and other proteins. Hence, the company aligned its business segments: BioDiscovery and Cell Culture Systems with its target markets. The company's total revenues increased at a CAGR of 18% during 2002-2006, from $648 million to $1,264 million. This represents an absolute total growth of +$615 million for total revenues during the same period. Invitrogen's biggest contributor to sales growth out to 2010 will be the BioDiscovery segment which includes the company's functional genomics, cell biology and drug discovery product lines.
[Studien Infos ausblenden]

Overview 1
Catalyst 1
Summary 1
Company Structure 6
Company Overview and Key Facts 6
Business Description 7
History 7
Locations and Subsidiaries 11
Company Financials 12
Stock Market Performance 12
P&L 14
Balance Sheet 16
Cash Flow 17
Business Segment Performance 17
Geographic Segment Performance 18
Products & Services 20
Marketed Products 20
Historical Product Sales 22
AC Forecast Product Sales 22
Competitors and Strategic Business Relationships 24
Key Competitors 24
Key Suppliers 24
Key Clients 24
Shareholding Structure 25
Strategy 26
Company View 26
Corporate Strategy 28
SWOT Analysis 30
Overview 30
Strengths 31
Weaknesses 32
Opportunities 33
Threats 34
Value Chain Analysis 35
Overview 35
Product Development 35
Manufacturing 35
Sales 36
Scorecard 37
Overview 37
Scorecard Analysis 38
Key Employees 39
List of Key Employees 39
Key Employee Biographies 40
Financial and Operational Overview 47
Financial and Operational Overview 47
APPENDIX 50
Ask the analyst 50
Datamonitor consulting 50
Disclaimer 50
[Inhaltsverzeichnis ausblenden]

Table 1: Invitrogen - Key Facts 6
Table 2: Invitrogen – Locations and Subsidiaries 11
Table 3: Invitrogen - Year-End Share Price and Market Capitalization, 2002-2006 ($) 12
Table 4: Invitrogen - Key Events Impacting Share Price Performance 13
Table 5: Invitrogen - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 14
Table 6: Invitrogen - Operating revenue cost ratio analysis, 2002-2006 (% of total revenues) 16
Table 7: Invitrogen – Balance Sheet, 2002-2006 ($ Mn) 16
Table 8: Invitrogen – Cash Flow, 2002-2006 ($ Mn) 17
Table 9: Invitrogen - Revenue Breakdown, 2002-2006 ($ Mn) 18
Table 10: Invitrogen - Geographic Breakdown, 2002-2006 ($ Mn) 19
Table 11: Invitrogen – Marketed Products 20
Table 12: Invitrogen - Historical Product Sales, 2002-2006 ($ Mn) 22
Table 13: Invitrogen - Forecast Sales, 2006-2010 ($ Mn) 22
Table 14: Invitrogen – Key Competitors 24
Table 15: Invitrogen – Key Clients 24
Table 16: Invitrogen - Key Shareholders 25
Table 17: Invitrogen - SWOT Analysis Summary 30
Table 18: Invitrogen – Value Chain Analysis 35
Table 19: Invitrogen - Scorecard 37
Table 20: Invitrogen - Key Employees 39
Table 21: Invitrogen - Financial and Operational Overview 47
Figure 1: Invitrogen - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 15

Figure 2: Invitrogen - Key Strategic Revenues, 2002-2006 ($ Mn) 18

Figure 3: Invitrogen - Key Strategic Revenues, 2006-2010 ($ Mn) 23
[Tabellenverzeichnis ausblenden]